“Getting to the Bottom” of Problem Helps Tampa Doctor Expand Practice

TAMPA, FL (November 24, 2006) – It’s not the kind of problem most people want to discuss with their friends, much less their doctor, but Dr. Linh Nguyen says it has become one of the keys to his successful practice in Florida.

Hemorrhoids are described as varicose veins of the colorectal area. The itching and pain are often endured versus being confronted with medical help. Then, when help is sought, the problem often requires surgery. “And that,” according to Nguyen, “is where this alternative has been bringing people to me. I am finding a need.”

The “alternative” Nguyen speaks of is a painless, non-surgical procedure that employs extremely low voltage direct current to the effected area. The process, promoted by Ultroid® Technologies, Inc. (St. Petersburg, Florida), has worldwide distribution with growing markets in the U.S., China and Europe.

According to Ultroid® CEO, Michael Cao, “Several points make the system attractive to both doctors and patients.” Doctors can perform the FDA recognized procedure, Cao notes, “without anesthesia and in their offices.” Cao goes on to add, “Patients learn Ultroid® is painless, requires no down-time and is covered by most insurers, including Medicare.”

Nguyen says that since employing Ultroid® as an alternative to painful surgery, he has seen a growth in referrals. “Referred business,” says Nguyen, “is definitive proof that the method is a success.” With the number of out-patient procedures performed in his office increasing, Nguyen feels certain he has found a hidden need and applied an increasingly popular service.

“Painless Hemorrhoid Treatment” Tops Google, Yahoo and MSN Searches

SAINT PETERSBURG, FL (November 30, 2006) - The phrase “painless hemorrhoid treatment” has been very good to Ultroid® Technologies, Inc., a Florida-based corporation specializing in the production of a unique, FDA approved hemorrhoid therapy product.

Being at the top of any search engine is the goal of most companies. The top is where most websurfers start when looking for a particular topic and that can be directly translated into profits. With more than 100 million web sites indexed, finding what you want is best left to the Big Three–Google, Yahoo and MSN. Those three search engines reportedly account for as much as 80 percent of the topic queries. So when Ultroid® announced this week that they were topping those three major search engines, it was clearly a cause for celebration for the company.

“Painless hemorrhoid treatment is how we describe the Ultroid® process,” said Ultroid® CEO, Michael Cao. “We have stressed that point in our advertising and with the doctors that use the product worldwide,” he said. Cao also noted, “It has taken a lot of hard work from a lot of dedicated people and it doesn’t end here.”

The Ultroid® Treatment System is a virtually painless, micro-current tool. Characterized in their literature as a “breakthrough device,” Ultroid® is the only company to market the patented product. Recognized by Medicare and most insurers the treatment is quick and simple. It is performed without anesthesia and, usually, in the doctor’s office. Ultroid® claims a world-wide client base.

Being at the top is a fickle position. With so many companies trying to accomplish the same thing, it is common to find the search position change on a daily basis which only makes attaining number one on three of the engines so unusual. Some of the help Cao referred to is from Manage One Solutions a search engine optimization company. Cao says, “Their job is to find ways to put their clients at the very top and, at least with “painless hemorrhoid treatment,” they hit the spot.”

Major Health Industry Rep Grabs "Painless Hemorrhoid Treatment"

DENVER, CO (December 11, 2006) - Health Industry Representatives Association (HIRA) of Denver today announced the addition of St. Petersburg, Florida-based Ultroid® Technologies, Inc. to its growing group of member manufacturers.

HIRA is a cooperative alliance of sales professionals, customers and manufacturers in the health care marketplace whose affiliations economically benefit its members. Ultroid® is a manufacturer of a unique device in a very promising market, according to Ultroid® CEO Michael Cao. He then added, "The rapid growth of Ultroid® as a force in the vascular repair industry makes our product extremely interesting to clinics, hospitals and private practitioners."

Ultroid® Technologies manufactures a "painless hemorrhoid treatment" device. The Ultroid® System offers hemorrhoid patients a quick, non-surgical and painless method of hemorrhoid treatment. The procedure is recognized by the FDA, Medicare and most insurers. Doctors find the system a welcome, easy-to-use addition to their practices by being able to perform the hemorrhoid procedure in their office without the need of anesthesia. Relieved patients are capable of walking away and returning to their normal routines, immediately after treatment.

Cao said the inclusion of HIRA is a major contribution to Ultroid®'s recently announced plans to expand its sales markets. "With HIRA's market knowledge," Cao explained, "the Ultroid® System will become increasingly widespread." "There is little doubt," Cao said, "that this is a strongly beneficial move for both parties."

Former Mayor Joins Ultroid®’s “Blue Chip” Board of Advisors

Saint Petersburg, FL (December 8, 2006) – Ultroid® Technologies, Inc., a vascular management company based in this city, specializing in painless hemorrhoid treatment, has announced the addition of former St. Petersburg mayor, Robert L. Ulrich to its board of advisors.

Advising management teams is nothing new for the former, two-time mayor. Among his credits, former and current, Ulrich counts at least three chairmanships, CEO to two area financial institutions, director of another, a vice-president for the area Chamber of Commerce and a trustee to Florida Southern College and the Salvador Dali Museum. As a practicing attorney, Ulrich continues an active business life.

Ultroid® CEO Michael Cao says, “Mr. Ulrich’s business experiences make him a good fit for this blue chip advisory board. Along with other well-known members of the national business community, Mr. Ulrich lends his expertise and reputation to an already substantial collection of experts.”

Ultroid® Technologies (www.ultroid.com) recently burst into the medical arena with its painless hemorrhoid treatment. Within a year, it began topping many of the web’s search engines as curiosity about the non-surgical process and the company grew. Ultroid® claims ownership and sole marketing possession of its patented micro-electronic treatment for hemorrhoids.

BellSouth Yellow Pages Group President Joins Hemorrhoid Treatment Leader

ATLANTA, GA (January 3, 2007) – Former BellSouth Yellow Pages executive, Elmer Smith has become a major shareholder and member of the board of advisors to Ultroid® Technologies, Inc. of Saint Petersburg, Florida. Smith, whose 40-year career with BellSouth ended with retirement in 2005, was group president of the advertising and publishing arm of BellSouth Corporation. During his tenure, Smith was instrumental in the joint acquisition of YellowPages.com by BellSouth and AT&T.

Smith noted, “My involvement with Ultroid® allows me to continue exercising a keenly acquired knowledge of promotion with a highly promising corporation.” Smith’s position with the hemorrhoid remedy leader is seen as strengthening an already growing corporate presence in the expanding vascular field.

Ultroid® CEO, Michael Cao is delighted with Smith’s decision to add his name to the growing list of corporate advisors. “Mr. Smith’s abilities are accepted fact,” notes Cao. “His presence beneath our corporate umbrella brings added credibility to the Ultroid® name,” Cao added.

Ultroid® is well-known in medical circles as a non-surgical, painless hemorrhoid treatment. Cao says, the appointment of Smith is an added effort toward public awareness of the Ultroid® name beyond the medical world.

About Ultroid® Technologies, Inc.:

Ultroid® Technologies, Inc. (Saint Petersburg, FL) manufactures and markets the Ultroid™ system for painless hemorrhoid treatment. Malpractice insurers report no need for increased premiums because of the procedure’s noninvasive nature. The non-surgical technology is a break-through in painless hemorrhoid therapy requiring no anesthesia and no patient-healing down time. Performed in the doctor’s office in minutes, patients are immediately able to resume their daily activities. Ultroid™ is covered by most major insurers and Medicare.

Cases are on the Rise Claims Texas Doc Using Painless Hemorrhoid Treatment

HOUSTON, TX (December 19, 2006 ) –- Some call it too much of the good life. Nationally, an increase in hemorrhoid cases is being reported according to medical giant Johnson and Johnson (NYSE: JNJ News). Some estimates claim as many as one million additional complaints requiring medical care are added each year. Doctor Dac Vu says an increase in hemorrhoid complaints in Houston has boosted traffic to his Center for Integrated Medicine. The doctor says he cannot attribute the growing number of clinic patients looking for hemorrhoid relief to any one cause but feels recent efforts at the clinic to educate patients about the often embarrassing condition may be partly responsible. “That,” says the doctor, “and the fact that we offer a non-surgical solution.”

According to Vu, most people are familiar with the term “hemorrhoid” as a painful and embarrassing medical condition. “But we all have hemorrhoid tissue,” Vu says. Hemorrhoids are an essential part of our anatomy, according to the doctor.

“What most people don’t understand,” says Vu, “is that hemorrhoids are cushions, a part of the normal anatomy and physiology within the anal canal.” They perform important functions in maintaining continence as an individual coughs, strains or sneezes. “The cushions fill with blood constricting the area to prevent unwanted leakage,” Vu explains. In short, hemorrhoids are a wanted, needed, even essential part of our anatomy.

Swollen hemorrhoid tissue often itches, is uncomfortable and may even be painful. That is the hemorrhoid we look to our doctors for help against. “For the physician,” Vu says, “it is wise to inform the patient about the value and purpose of hemorrhoid tissue as a normal part of the anatomy.” Even more important, it is valuable to know that surgical removal may result in varying degrees of incontinence that becomes worse with age.

Vu is treating patients with a non-invasive system called “Ultroid®.” The Ultroid® system (http://www.ultroid.com), says Vu, “has the patient treated in the office in a short time and back to their regular schedule the same day”—without surgery. This is a notable advantage over surgery, where there can be considerable pain after cutting as the anus tightens and relaxes. Healing may take as long as two weeks. Vu says, “Ultroid® has taken away much of the ordeal and all of the pain associated with hemorrhoid therapy--enough that patients inquire about the procedure far more frequently than previously.

About Ultroid® Technologies, Inc.:

Ultroid® Technologies, Inc. (St Petersburg, FL) manufactures and markets the Ultroid™ system for painless hemorrhoid treatment. Malpractice insurers report no need for increased premiums because of the procedure’s noninvasive nature. The non-surgical technology is a break-through in painless hemorrhoid therapy requiring no anesthesia and no patient-healing down time. Performed in the doctor’s office in minutes, patients are immediately able to resume their daily activities. Ultroid™ is covered by most major insurers and Medicare.

About Dr. Dac Vu:

Dac Vu, MD is President & Medical Director of the Center for Integrated Medicine in Houston, Texas and a certified Diplomate of the American Board of Internal Medicine. A former clinical instructor for physicians in training in primary care at Pacific Hospital of Long Beach, California, Vu was voted the “Clinical Educator of the Year” in 1997- 98 and was later recruited as CEO of a community hospital in Houston, Texas.

In June 2000, the doctor opened his private practice with a multi-tier approach to patient care developing one of the largest adult day care centers in Houston, Texas. Dr. Vu is part of the medical staff at Memorial Hermann Southwest, West Houston Medical Center and is a member of the Texas Medical Association and Harris County Medical Society.

Google, Yahoo, MSN Leader Registers “Painless Hemorrhoid Treatment”
Ultroid Service Mark Tops Searches on Big Three

SAINT PETERSBURG, FL (January 10, 2007) – Now, when you hear the phrase “the painless hemorrhoid treatment” you’ll be thinking of Ultroid®—at least that’s the idea. Ultroid® Technologies, Inc. (http://www.ultroid.com) has registered the words as a service mark for their hemorrhoid treatment product. The Florida-based corporation’s Ultroid® Hemorrhoid Treatment System, as approved by the FDA, has been making strong moves in the market toward national recognition in conjunction with their already growing international presence.

“Topping Google, Yahoo and MSN for several months with that phrase seemed a natural for our marketing,” said Ultroid® CEO, Michael Cao. Name recognition through marketing is the key to any business according to Cao. Ultroid has been taking his words to heart and the effort has proved valuable with distributors now supplying markets throughout the U.S. with a sizeable effort in Asia, as well.

Rubber bands that painfully wring the life out of the hemorrhoid; staples that do much the same; and lasers that burn the area are all uncomfortable, trendy solutions. But now, as patients experience serious complications, including sepsis and death from some types of alternative procedures, they are left with the prospect of painful surgery and long, expensive recuperative periods as their only choice. Enter: Ultroid®.

The Ultroid® system has long been promoted as a painless, non-surgical remedy. Using a low amperage direct current, so low the patient seldom feels anything more than a slight tingling sensation, the doctor can apply the Ultroid® technique in the office with the procedure taking only a few minutes. Malpractice insurers look at the non-surgical procedure as safe enough that no additional malpractice premiums are charged to doctors using Ultroid®. “It allows the patient a non-surgical, painless resolve to what could otherwise be a prolonged and uncomfortable healing period,” according to Cao. “It affords the doctor,” Cao adds, “confidence in the product without the added liability.” Cao also notes there is no prolonged healing period as patients leave the doctor’s office within minutes to resume their normal daily routines.

So, what’s the catch? “There is none,” Cao says. “This is a completely safe, painless, cost-effective means to conquer a very personal problem most of us share.” Approximately 80 percent of us will suffer from hemorrhoids in our lifetime, Cao notes. Dealt with early, the problem is easily solved. But most of us avoid the problem because of the embarrassment. The result is that the condition only worsens. Cao adds, “Ultroid® makes the solution so much easier. It becomes a problem shared with your family doctor.” Hospitals, surgeons, anesthetists and any number of assisting hospital employees are avoided. “Ultroid® solves the problem, simply,” Cao claims.

The logic is inescapable. Litigation threats are ringing in industry ears causing marketers to reconsider their liability risk. Meanwhile, Ultroid® is comfortably riding the wave of the demand for a “painless hemorrhoid treatment.”

World’s Largest Market Opens to “Painless Hemorrhoid Treatment”

SHANGHAI, CHINA (January 19, 2007) – Ultroid® Technologies, Inc. of Saint Petersburg, Florida (www.ultroid.com), makers of the Ultroid® Hemorrhoid System has just acquired importation rights of its “painless hemorrhoid treatment” in the People’s Republic of China.

CEO Michael Cao claims the accomplishment is the biggest news, thus far, for this fast-growing company. “We have sought and found markets throughout the U.S., Canada, Central and South America and even Europe. Asia was always included as a reasonable goal. China, however, is a vastly larger market than any we have previously encountered and we welcome its addition.”

With nearly one-and-a-half billion people, or about one-third of the world’s population, China is the largest single market. “The distribution of Ultroid® into the Asian market will see major expansion in our yearly output,” Cao said. “More important,” he notes, “is the certainty that Ultroid® will become a brand whose name equals the process--as in Kleenex equating to tissue or Johnson & Johnson’s BAND-AID equating to a bandage.” Cao says he fully expects that“painless hemorrhoid treatment” will become synonymous with Ultroid. With that thought in mind, Ultroid® recently made “the painless hemorrhoid treatment” their service mark.

Cao alluded to a future announcement of further expansion into other world markets. “We have been energetically pursuing distributional avenues throughout the world,” Cao said. “China is a rare plum,” he added.

Legal Eagle Accepts Presidential Post of Expanding Medical Corp.

SAINT PETERSBURG, FL (January 19, 2007) – “I promised you I would find and continue to collect the finest organizational minds to help push Ultroid® Technologies (www.ultroid.com) into the world corporate arena,” a visibly pleased CEO Michael Cao, claimed as he announced the appointment of Gerald Spurgin as the new president of the Florida-based corporation.

Spurgin a former member of Tampa’s Holland & Knight recently left Florida’s Morgan and Morgan, one of the nation’s leading legal firms to accept the position at Ultroid. A member of the Florida Bar for more than 22 years, Spurgin is an “AV- rated” lawyer specializing in corporate and tort litigation. He has represented numerous publicly traded and Fortune 500 companies in bio-medical device product liability, medical negligence liability, corporate litigation and commercial transactions.

Ultroid® Technologies, Inc. produces the Ultroid® hemorrhoid management system, a painless alternative to hemorrhoid surgery. Recent market expansion has included several outlets in North America and a promise from Cao of an impending announcement of an entry into the Asian market.

Appearing tanned and fit after a brief vacation before taking on his newest assignment, Spurgin expressed optimism with Ultroid®’s rapid growth and increasing notoriety. “This is a corporation that produces a superior, painless product,” he said, “which continues to find new markets every day.” Spurgin claimed it would be his job to see to it that the growth continued and that “the public will grow to know Ultroid® Technologies as the leader in painless hemorrhoid treatment,” he concluded.

Asian Markets Welcome Painless Hemorrhoid Treatment
Ultroid® Adds Distribution in 25 Pacific Rim Nations

SINGAPORE (January 22, 2007) – Adding to their growing list of nations, Ultroid® Technologies CEO Michael Cao today announced, “The Far Eastern market is complete.” The Florida-based medical manufacturer says the distribution rights to the Ultroid® painless hemorrhoid treatment now include an additional twenty-five Pacific Rim nations. Asian Medical, Inc., based in Singapore and Sarasota, FL, has been named the exclusive distributor for Ultroid® products in that region.

Added to their previous announcement of distributors in China, Ultroid® now counts Hong Kong, Taiwan, Japan, Korea and the Philippines among the most recent areas where the painless hemorrhoid treatment can be found. “With the addition of these geographic areas, Australia and New Zealand,” Cao noted, “it is safe to say Ultroid® is serving well over half of the world’s population.”

Ultroid® has been making advances with their non-surgical hemorrhoid procedure in many world markets. The recent addition of Asian Medical as their latest regional distributor places the Ultroid name into one of the world’s most dynamic economies. Cao attributes Ultroid®’s recent growth to its aggressive marketing strategy, and corporate managerial additions.

Ultroid® President Gerald Spurgin hinted that the corporation’s next move may be in the retail arena. “Ultroid® is not only the name of our hemorrhoid treatment product,” Spurgin noted. “It will grow to represent,” he said, “the most successful group of treatments and remedies for hemorrhoids.” Spurgin, who recently joined Ultroid® said, “We intend to make the name part of everyone’s vocabulary.”

Money Man Joins Growing Medical Manufacturer
Ultroid Adds Michael Knox to Executive Collection

TAMPA, FL (February 5, 2007) – “When things are good, they only get better,” according to Michael Cao, CEO of Tampa Bay’s Ultroid® Technologies, Inc. at the announcement of the addition of Tampa CPA Michael Knox as the growing corporation’s new CFO.

Ultroid® Technologies’ rocket-like emergence in the painless hemorrhoid treatment field is largely due, according to Cao, to the acquisition of strong business personalities. Mr. Knox’s client list is a Who’s Who of major business including several Fortune 500 companies. “His service to them is strong and unquestioned,” Cao said. “His reputation and participation are an endorsement of our development plans,” Cao noted.

Knox sees his duties as CFO as opportune for Ultroid®. “Growth continues to be an asset for Ultroid®,” Knox said. “Expansion opportunities are also presenting themselves,” Knox claimed. “I have come aboard in time to turn those opportunities into reality by directing the next phase of development,” he added.

Knox joins Ultroid® Technologies, Inc. as the corporation announces distribution expansion in more than 26 Asian countries including China, Japan, Korea and Singapore and now serves more than half the world’s population. The Ultroid® painless hemorrhoid treatment is a non-invasive alternative to hemorrhoid surgery.

Mr. Knox, a Florida certified public accountant and certified valuation analyst, has worked in public and private accounting for more than 15 years. He is a member in good standing with the American Institute of Certified Public Accountants, the Florida Institute of Certified Public Accountants, the National Association of Certified Valuation Analysts and the Tampa Bay Estate Planning Council.

Asian Markets Expanding for Painless Hemorrhoid Treatment
Ultroid® Gets FDA Export Papers

SAINT PETERSBURG, FL (February 13, 2007) – Moving ahead with their plans for distributor expansion, Florida-based Ultroid® Technologies, Inc. has announced the acquisition of Certificates to Foreign Governments from the U.S. Food and Drug Administration to coincide with a promotional swing through selected Asian sites by the company’s CEO.

“This is simply another step in expanding our sales base,” according to Ultroid® Technologies President, Michael Cao. Speaking from Hong Kong, Cao explained, “The certificates guarantee nothing when exporting,” he said. “However, they can make the product move more quickly through busy ports like Hong Kong and Singapore by assuring those governments of the product’s authenticity.”

According to Ultroid® President Gerald Spurgin, the company manufactures a painless alternative to invasive surgery. Described as a non-invasive, microelectronic device, “the machinery,” according to Spurgin, “is small enough to fit in a briefcase-sized carrier,” increasing its appeal to physicians as a mobile tool. Spurgin claims intense interest in the product has necessitated the Asian promotional swing.

The certificates list the products for export to more than 26 nations, mostly along the Pacific Rim and are verified by the US Food and Drug Administration as items marketed and legally exported from the US. Cao’s current Asian tour includes Vietnam, Singapore and Hong Kong. Ultroid®’s list of distributors has recently expanded to include distributors in most Asian countries.